Ardelyx ARDX Stock
$6.19
0.161816%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.53B
LOW - HIGH [24H]
$6.14
-
$6.38
VOLUME [24H]
$2.87M
P/E Ratio
0
Earnings per share
-$0.24
ISIN
US0396971071
Ardelyx Price Chart
Ardelyx ARDX Financial and Trading Overview
| Ardelyx stock price | 6.19 USD |
| Previous Close | 6.05 USD |
| Open | 6.09 USD |
| Bid | 4.58 USD x 200 |
| Ask | 7.8 USD x 200 |
| Day's Range | 6.08 - 6.42 USD |
| 52 Week Range | 3.49 - 8.4 USD |
| Volume | 4.86M USD |
| Avg. Volume | 3.63M USD |
| Market Cap | 1.57B USD |
| Beta (5Y Monthly) | 0.576 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.3 USD |
ARDX Valuation Measures
| Enterprise Value | 1.57B USD |
| Trailing P/E | N/A |
| Forward P/E | 12.36653 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6793418 |
| Price/Book (mrq) | 10.581395 |
| Enterprise Value/Revenue | 3.67 |
| Enterprise Value/EBITDA | -46.099 |
Trading Information
Ardelyx Stock Price History
| Beta (5Y Monthly) | 0.576 |
| 52-Week Change | 66.66% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 8.4 USD |
| 52 Week Low | 3.49 USD |
| 50-Day Moving Average | 6.15 USD |
| 200-Day Moving Average | 6.12 USD |
ARDX Share Statistics
| Avg. Volume (3 month) | 3.63M USD |
| Avg. Daily Volume (10-Days) | 3.83M USD |
| Shares Outstanding | 247.03M |
| Float | 219.85M |
| Short Ratio | 5.83 |
| % Held by Insiders | 3.18% |
| % Held by Institutions | 70.67% |
| Shares Short | 24.78M |
| Short % of Float | 10.25% |
| Short % of Shares Outstanding | 10.02% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -13.57% |
| Operating Margin (ttm) | -34.71% |
| Gross Margin | 74.55% |
| EBITDA Margin | -7.96% |
Management Effectiveness
| Return on Assets (ttm) | -5.11% |
| Return on Equity (ttm) | -39.45% |
Income Statement
| Revenue (ttm) | 427.68M USD |
| Revenue Per Share (ttm) | 1.76 USD |
| Quarterly Revenue Growth (yoy) | 27.50% |
| Gross Profit (ttm) | 318.86M USD |
| EBITDA | -34049000 USD |
| Net Income Avi to Common (ttm) | -58060000 USD |
| Diluted EPS (ttm) | -0.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 238.07M USD |
| Total Cash Per Share (mrq) | 0.96 USD |
| Total Debt (mrq) | 234.13M USD |
| Total Debt/Equity (mrq) | 157.53 USD |
| Current Ratio (mrq) | 3.485 |
| Book Value Per Share (mrq) | 0.602 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36263000 USD |
| Levered Free Cash Flow (ttm) | 86.38K USD |
Profile of Ardelyx
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 400 Fifth Avenue |
| ZIP | 02451 |
| Phone | 510 745 1700 |
| Website | https://www.ardelyx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 489 |
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Q&A For Ardelyx Stock
What is a current ARDX stock price?
Ardelyx ARDX stock price today per share is 6.19 USD.
How to purchase Ardelyx stock?
You can buy ARDX shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ardelyx?
The stock symbol or ticker of Ardelyx is ARDX.
Which industry does the Ardelyx company belong to?
The Ardelyx industry is Biotechnology.
How many shares does Ardelyx have in circulation?
The max supply of Ardelyx shares is 247.03M.
What is Ardelyx Price to Earnings Ratio (PE Ratio)?
Ardelyx PE Ratio is now.
What was Ardelyx earnings per share over the trailing 12 months (TTM)?
Ardelyx EPS is -0.24 USD over the trailing 12 months.
Which sector does the Ardelyx company belong to?
The Ardelyx sector is Healthcare.
Ardelyx ARDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25476.64 USD — |
-0.43
|
14.18B USD — | 25354.66 USD — | 25840.56 USD — | — - | 14.18B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31424.39 USD — |
-0.43
|
— — | 31273.93 USD — | 31873.27 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
6853.11 USD — |
+1.52
|
— — | 6790.49 USD — | 6916.92 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2297.61 USD — |
-0.55
|
— — | 2291.88 USD — | 2327.27 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6279.39 USD — |
+1.52
|
— — | 6222.02 USD — | 6337.86 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1203.64 USD — |
+1.6
|
— — | 1192.12 USD — | 1213.64 USD — | — - | — — |
- {{ link.label }} {{link}}